NEWTOWN, PA — Helius Medical Technologies, Inc. (Nasdaq: HSDT) has announced a 1-for-50 reverse split of its Class A common stock, set to take effect at 5:00 pm Eastern time on June 30, 2025. Starting July 1, 2025, the company’s stock will trade on The Nasdaq Capital Market on a split-adjusted basis under the existing ticker symbol “HSDT.”
The reverse stock split, approved by shareholders during a special meeting on May 23, 2025, is part of the company’s effort to meet Nasdaq’s continued listing requirements. Helius’ Board of Directors selected the split ratio of 1-for-50 within the approved range of 1-for-2 to 1-for-250.
Under the reverse split, every 50 shares of common stock will be consolidated into one share, reducing the total outstanding shares from approximately 33.8 million to 0.7 million. The company’s authorized shares remain unchanged at 150 million, and the par value of $0.001 per share also remains the same.
For shareholders, the reverse split will proportionately reduce the number of shares they hold, while increasing the per-share conversion and exercise prices of their stock options and warrants. Any fractional shares resulting will be rounded down to the nearest whole share, with shareholders receiving cash equivalent to the market value of the fractional shares as of the last trading day before the split takes effect.
Following the adjustment, the common stock will adopt a new CUSIP number, 42328V 876, to reflect the reverse split.
Helius Medical Technologies emphasized that the move aligns its stock price with Nasdaq requirements and supports the company’s ongoing efforts to maintain its listing status. Further details about the reverse split are available in the company’s proxy statement filed with the SEC on May 2, 2025.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.